Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer.

Breast cancer research and treatment - 1 Feb 2012

Banys Malgorzata, Krawczyk Natalia, Becker Sven, Jakubowska Jolanta, Staebler Annette, Wallwiener Diethelm, Fehm Tanja, Rothmund Ralf

Abstract excerpt

Recent studies have shown that the detection of circulating tumor cells (CTC) pre and postoperatively in the peripheral blood of primary breast cancer patients may be an indicator for poor survival. This study aimed to investigate the influence of removal of the primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer. 209 primary breast cancer patients could be included into...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Ductal, Breast

Share to Carcinoma, Lobular

Share to Cell Count

Share to Neoplasm, Residual

Share to Neoplastic Cells, Circulating

Share to Receptors, Steroid

Source

Identifiers

PMID: 21562707
DOI: 10.1007/s10549-011-1569-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer.PMID 21562707Read ↗

Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.Semantic proximity Read ↗

Circulating Tumor Cells in Breast Cancer: Correlation with Clinicopathological Parameters, Hormone Profile and MicroRNA Polymorphisms.Semantic proximity Read ↗

Minimal residual disease in breast cancer and gynecological malignancies: phenotype and clinical relevance.Semantic proximity Read ↗

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.Semantic proximity Read ↗

Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs.Semantic proximity Read ↗

Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds.Semantic proximity Read ↗

Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.Semantic proximity Read ↗

Transcription phenotype of circulating tumor cells in non-metastatic breast cancer.Semantic proximity Read ↗

Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapy.Semantic proximity Read ↗

Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancerSemantic proximity Read ↗

Perioperative circulating tumor cell detection: Current perspectives.Semantic proximity Read ↗

Lymph-Circulating Tumor Cells show distinct properties to Blood-Circulating Tumor Cells and constitute extraordinary efficient metastatic precursorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.